NGNE financials
Neurogene (NGNE) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
NGNE income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | – | -$103.33M | -$90.35M | -4.24 |
| 2024 | $925.00K | – | -$82.61M | -$75.14M | -4.28 |
| 2023 | $0.00 | – | -$55.58M | -$36.32M | -117.28 |
| 2022 | – | – | -$56.52M | -$55.19M | -139.88 |
| 2021 | – | – | -$60.70M | -$60.69M | -5.50 |
| 2020 | – | – | -$33.73M | -$33.28M | -3.20 |
- NGNE revenue was $0.00 in fiscal 2025, net income -$90.35M.
Updated 2026-11-10 04:46 UTC